F Mahfoud, C Ukena, RE Schmieder, B Cremers… - Circulation, 2013 - Am Heart Assoc
Background—Catheter-based renal sympathetic denervation (RDN) reduces office blood pressure (BP) in patients with resistant hypertension according to office BP. Less is known …
WL Verloop, EE Vink, M Voskuil, E Vonken… - Journal of …, 2013 - journals.lww.com
Objective: Percutaneous renal denervation (pRDN) is a new and promising therapy for resistant hypertension. Among patients suspected of having resistant hypertension, the …
Background Vitamin D deficiency is associated with hypertension; however, it is unclear whether vitamin D influences therapeutic blood pressure reduction. Renal sympathetic …
F Mahfoud, O Vonend, U Kintscher, S Ewen, J Floege… - Der Kardiologe, 2013 - Springer
Zusammenfassung Dieses Positionspapier ist eine Stellungnahme der Deutschen Gesellschaft für Kardiologie–Herz-und Kreislaufforschung eV, der Deutschen Gesellschaft …
M Schmidt, F Roessner, M Berger… - Journal of Thoracic …, 2019 - journals.lww.com
Objectives: Left ventricular (LV) hypertrophy in resistant hypertensive patients is associated with a reduced intramyocardial perfusion. Renal sympathetic denervation (RDN) has been …
F Mahfoud, M Böhm, LC Rump, O Vonend… - …, 2013 - Am Heart Assoc
In disagreement with several other studies, the authors report no significant overall blood BP lowering effect after RDN in a small group of 12 patients, and not surprisingly did not …
Die arterielle Hypertonie gehört in den westlichen Industrienationen mit ihrer hohen Prävalenz zu den häufigsten chronischen Erkrankungen und ist ein Hauptrisikofaktor für …
LK Olsen, AL Kamper, JH Svendsen, LE Bang… - Blood …, 2014 - Taylor & Francis
Percutaneous renal denervation is a new treatment option for patients with resistant hypertension and little is known about the eligibility of patients referred. 100 consecutive …
Hypertension is the primary risk factor for cardiovascular and renal-disease endpoints. Medications help many patients but not all. Recently, two device-related treatments have …